Thermo Fisher Scientific (TMO)

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSESOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on Solventum’s recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc NYSE: TMONYSETMO)

Thermo Fisher Scientific Inc. (NYSETMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum NYSE: SOLVNYSESOLV)

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET).

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on April 15, 2025, to shareholders of record as of March 14, 2025. This reflects an 10% increase over the previous dividend payment of $0.39.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO designed to increase access to renewable electricity across the pharmaceutical and healthcare supply chains. The Lorca solar project is expected to be operational in early 2026 and includes a cohort of three partners from the pharmaceutical and healthcare sectors.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2024.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. (EST).

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2024 before the market opens on Thursday, January 30, 2025, and will hold a conference call on the same day at 8:30 a.m. EST.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares) of its common stock. As of December 3, 2024, $3 billion remained available under the company’s share repurchase authorization.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining.

BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQMYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. NYSE: TMONYSETMO)

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Wolfe Healthcare Conference on Tuesday, November 19, 2024 at 8:00 a.m. (EDT).

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on January 15, 2025, to shareholders of record as of December 13, 2024.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2024.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2024 before the market opens on Wednesday, October 23, 2024, and will hold a conference call on the same day at 8:30 a.m. EDT.

Here are brief overviews of five Nasdaq stocks, tailored to highlight their strengths and receive public attention:

Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQPRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands NASDAQ: KAVLNASDAQKAVL)(NASDAQ: BNZINASDAQBNZI, which saw a 97.51% rally after announcing a favorable share structure, Battalion Oil Corp (NASDAQ: BATLNASDAQ) on merger news, and Treasure Global Inc. (NASDAQ: TGLTGL) , experiencing unusual high volume on its innovative ZCITY Super App. Keep these stocks on your radar for potential moves. See more in-depth information below.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, hosted its 2024 Investor Day today and provided an in-depth review of the company’s proven growth strategy and its industry-leading businesses, which consistently deliver best-in-class products and services that are essential to the work performed by its customers around the world.

Agilent Technologies Inc. (NYSEA) is a diversified global leader in the life sciences, diagnostics and applied chemical markets.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 8:30 a.m. (EDT).

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2024.

Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on October 15, 2024, to shareholders of record as of September 13, 2024.

To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial. By testing patients’ bone marrow and blood for certain genetic biomarkers using Thermo Fisher’s next-generation sequencing (NGS) technology, clinical sites can more quickly match patients with an appropriate clinical trial that tests a treatment designed to target specific mutations present in the samples.